Idera Pharmaceuticals Inc (NASDAQ:IDRA) issued its quarterly earnings data on Tuesday. The company reported ($0.12) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.08) by $0.04, American Banking News reports. Idera Pharmaceuticals Inc (NASDAQ:IDRA) stock performance was 11.02% in last session and finished the day at $2.82. Traded volume was 4,339,672 shares in the last session and the average volume of the stock remained 3.49 million shares. The beta of the stock remained 2.57. Idera Pharmaceuticals Inc (NASDAQ:IDRA) insider ownership is 0.60%.

Scientific Games Corp (NASDAQ:SGMS) last released its earnings data on Thursday, May 8th. The company reported ($0.53) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by $0.56. The company had revenue of $388.10 million for the quarter, compared to the consensus estimate of $421.02 million. Scientific Games Corp (NASDAQ:SGMS) rose 6.53% to $9.79 yesterday on volume of 3,013,754 shares. The intra-day range of the stock was $9.06 – 9.81. Scientific Games Corp (NASDAQ:SGMS) has a market capitalization of $824.82 million.

Origin Agritech Ltd. (NASDAQ:SEED) received a non-binding proposal letter dated May 12, 2014, from Hunan Xindaxin. In the letter, Xindaxin proposes to acquire the company for $2.50 a share. Origin Agritech said it is reviewing and evaluating the proposal, but says it has not yet made any decisions. Origin Agritech Ltd. (NASDAQ:SEED)’s stock on May 13, 2014 reported an increase 12.68% to the closing price of $2.31. Its fifty two weeks range is $1.17 – 3.47. The total market capitalization recorded $52.53 million. The overall volume in the last trading session was 1,273,658 shares. In its share capital, Origin Agritech Ltd. (NASDAQ:SEED) has 22.73 million outstanding shares.

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) issued its quarterly earnings data on Thursday. The company reported ($0.17) earnings per share for the quarter, meeting the analysts’ consensus estimate of ($0.17),Stock Ratings Network reports. The company had revenue of $3.50 million for the quarter, compared to the consensus estimate of $3.34 million. On Tuesday, shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) advanced 8.04% to close the day at $8.33. Company return on investment (ROI) is -106.20% and its monthly performance is recorded as -6.51%. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) quarterly revenue growth is -15.43%.